Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLVS

Clovis Oncology (CLVS)

Clovis Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLVS
DateTimeSourceHeadlineSymbolCompany
05/01/20233:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
04/14/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
04/06/20233:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
03/02/20237:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/16/20233:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/13/20235:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/10/20238:49AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLVSClovis Oncology Inc
01/12/20235:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/29/20228:36AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CLVSClovis Oncology Inc
12/13/20225:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/13/20225:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/12/20225:54AMDow Jones NewsClovis Oncology Shares Fall Premarket After Bankruptcy FilingNASDAQ:CLVSClovis Oncology Inc
12/11/202211:18PMBusiness WireClovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286NASDAQ:CLVSClovis Oncology Inc
11/16/20223:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
11/09/20227:12AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLVSClovis Oncology Inc
11/03/20223:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20223:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20223:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20223:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20223:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
10/27/20224:05PMBusiness WireClovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific RetreatNASDAQ:CLVSClovis Oncology Inc
10/17/20222:45AMBusiness WireClovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM CongressNASDAQ:CLVSClovis Oncology Inc
10/04/20223:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
10/03/20226:00AMBusiness WireTRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM MutationsNASDAQ:CLVSClovis Oncology Inc
09/21/20227:00AMBusiness WireClovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply AgreementNASDAQ:CLVSClovis Oncology Inc
09/13/20227:00AMBusiness WireClovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
09/12/20226:55AMTipRanksClovis (NASDAQ:CLVS) Jumps After Rubraca Shows Progression-Free Survival in Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
09/11/20229:30AMBusiness WireClovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk SubgroupsNASDAQ:CLVSClovis Oncology Inc
09/06/20223:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
09/06/20223:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CLVS